753 related articles for article (PubMed ID: 19137534)
41. Dibasic Derivatives of Phenylcarbamic Acid against Mycobacterial Strains: Old Drugs and New Tricks?
Malík I; Csöllei J; Solovič I; Pospíšilová Š; Michnová H; Jampílek J; Čížek A; Kapustíková I; Čurillová J; Pecháčová M; Stolaříková J; Pecher D; Oravec M
Molecules; 2018 Sep; 23(10):. PubMed ID: 30274224
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and in-vitro antimycobacterial activity of amino-5-[(substituted) phenyl]-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolylmethanethione.
Ali MA; Yar MS; Siddiqui AA; Husain A; Abdullah M
Acta Pol Pharm; 2007; 64(5):435-9. PubMed ID: 18540164
[TBL] [Abstract][Full Text] [Related]
45. Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines.
Tonelli M; Novelli F; Tasso B; Sparatore A; Boido V; Sparatore F; Cannas S; Molicotti P; Zanetti S; Parapini S; Loddo R
Bioorg Med Chem; 2014 Dec; 22(24):6837-45. PubMed ID: 25464882
[TBL] [Abstract][Full Text] [Related]
46. Preparation and antitubercular activities of alkylated amino alcohols and their glycosylated derivatives.
Taveira AF; Hyaric ML; Reis EF; Araújo DP; Ferreira AP; de Souza MA; Alves LL; Lourenço MC; Vicente FR; de Almeida MV
Bioorg Med Chem; 2007 Dec; 15(24):7789-94. PubMed ID: 17851083
[TBL] [Abstract][Full Text] [Related]
47. [Relation between chemical structure and antimycobacterial activity against atypical strains. XIII. Thiosalicylanilides].
Waisser K; Kubicová L; Gregor J; Budová J; Andrlová A; Drsata J; Odlerová Z
Ceska Slov Farm; 1998 Mar; 47(2):84-6. PubMed ID: 9650366
[TBL] [Abstract][Full Text] [Related]
48. Synthesis of 1-[3-(4-benzotriazol-1/2-yl-3-fluoro-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-3-substituted-thiourea derivatives as antituberculosis agents.
Dixit PP; Patil VJ; Nair PS; Jain S; Sinha N; Arora SK
Eur J Med Chem; 2006 Mar; 41(3):423-8. PubMed ID: 16494970
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and antitubercular activity of substituted novel pyrazoline derivatives.
Ali MA; Yar MS; Kumar M; Pandian GS
Nat Prod Res; 2007 Jun; 21(7):575-9. PubMed ID: 17613813
[TBL] [Abstract][Full Text] [Related]
50. N-substituted 2-isonicotinoylhydrazinecarboxamides--new antimycobacterial active molecules.
Rychtarčíková Z; Krátký M; Gazvoda M; Komlóová M; Polanc S; Kočevar M; Stolaříková J; Vinšová J
Molecules; 2014 Mar; 19(4):3851-68. PubMed ID: 24686575
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and antimycobacterial evaluation of pyrazinamide derivatives with benzylamino substitution.
Zitko J; Paterová P; Kubíček V; Mandíková J; Trejtnar F; Kuneš J; Doležal M
Bioorg Med Chem Lett; 2013 Jan; 23(2):476-9. PubMed ID: 23237840
[TBL] [Abstract][Full Text] [Related]
52. QSAR study of antimycobacterial activity of quaternary ammonium salts of piperidinylethyl esters of alkoxysubstituted phenylcarbamic acids.
Waisser K; Dolezal R; Palát K; Cizmárik J; Kaustová J
Folia Microbiol (Praha); 2006; 51(1):21-4. PubMed ID: 16821706
[TBL] [Abstract][Full Text] [Related]
53. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.
Martins F; Santos S; Ventura C; Elvas-Leitão R; Santos L; Vitorino S; Reis M; Miranda V; Correia HF; Aires-de-Sousa J; Kovalishyn V; Latino DA; Ramos J; Viveiros M
Eur J Med Chem; 2014 Jun; 81():119-38. PubMed ID: 24836065
[TBL] [Abstract][Full Text] [Related]
54. Substituted hydrazinecarbothioamide as potent antitubercular agents: synthesis and quantitative structure-activity relationship (QSAR).
Singh S; Mandal PK; Singh N; Misra AK; Singh S; Chaturvedi V; Sinha S; Saxena AK
Bioorg Med Chem Lett; 2010 Apr; 20(8):2597-600. PubMed ID: 20304645
[TBL] [Abstract][Full Text] [Related]
55. Antitubercular agents. Part 1: synthesis of phthalimido- and naphthalimido-linked phenazines as new prototype antitubercular agents.
Kamal A; Hari Babu A; Venkata Ramana A; Sinha R; Yadav JS; Arora SK
Bioorg Med Chem Lett; 2005 Apr; 15(7):1923-6. PubMed ID: 15780634
[TBL] [Abstract][Full Text] [Related]
56. Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J
Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254
[TBL] [Abstract][Full Text] [Related]
57. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
[TBL] [Abstract][Full Text] [Related]
58. New antituberculotics originated from salicylanilides with promising in vitro activity against atypical mycobacterial strains.
Imramovský A; Vinsová J; Férriz JM; Dolezal R; Jampílek J; Kaustová J; Kunc F
Bioorg Med Chem; 2009 May; 17(10):3572-9. PubMed ID: 19403314
[TBL] [Abstract][Full Text] [Related]
59. New S-benzylisothiosemicarbazones with antimycobacterial activity.
Petrlíková E; Waisser K; Heinisch L; Stolaříková J
Folia Microbiol (Praha); 2011 Jan; 56(1):10-2. PubMed ID: 21394476
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
Rai D; Johar M; Srivastav NC; Manning T; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2007 Sep; 50(19):4766-74. PubMed ID: 17696514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
